Seguir
john isaacs
john isaacs
Professor of Oncology
Dirección de correo verificada de jhmi.edu
Título
Citado por
Citado por
Año
AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer
ES Antonarakis, C Lu, H Wang, B Luber, M Nakazawa, JC Roeser, ...
New England Journal of Medicine 371 (11), 1028-1038, 2014
27862014
Hedgehog signalling in prostate regeneration, neoplasia and metastasis
SS Karhadkar, G Steven Bova, N Abdallah, S Dhara, D Gardner, A Maitra, ...
Nature 431 (7009), 707-712, 2004
13732004
KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11. 2
JT Dong, PW Lamb, CW Rinker-Schaeffer, J Vukanovic, T Ichikawa, ...
Science 268 (5212), 884-886, 1995
12651995
Activation of programmed cell death in the rat ventral prostate after castration
N Kyprianou, JT Isaacs
Endocrinology 122 (2), 552-562, 1988
9091988
Etiology and disease process of benign prostatic hyperplasia
JT Isaacs, DS Coffey
The Prostate 15 (S2), 33-50, 1989
8721989
A history of prostate cancer treatment
SR Denmeade, JT Isaacs
Nature Reviews Cancer 2 (5), 389-396, 2002
7702002
Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation
N Kyprianou, HF English, JT Isaacs
Cancer research 50 (12), 3748-3753, 1990
6681990
Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene
B Levine, Q Huang, JT Isaacs, JC Reed, DE Griffin, JM Hardwick
Nature 361 (6414), 739-742, 1993
6421993
Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer
SR Denmeade, XS Lin, JT Isaacs
The prostate 28 (4), 251-265, 1996
5941996
Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation
N Kyprianou, HF English, NE Davidson, JT Isaacs
Cancer research 51 (1), 162-166, 1991
5571991
Adaptation versus Selection as the Mechanism Responsible for the Relapse of Prostatic Cancer to Androgen Ablation Therapy as Studied in the Dunning R-3327 …
JT Isaacs, DS Coffey
Cancer research 41 (12_Part_1), 5070-5074, 1981
5351981
Expression of transforming growth factor-β in the rat ventral prostate during castration-induced programmed cell death
N Kyprianou, JT Isaacs
Molecular Endocrinology 3 (10), 1515-1522, 1989
5321989
Establishment and characterization of seven Dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers
JT Isaacs, WB Isaacs, WFJ Feitz, J Scheres
The Prostate 9 (3), 261-281, 1986
5301986
Antagonistic effect of androgen on prostatic cell death
JT Isaacs
The Prostate 5 (5), 545-557, 1984
5211984
Implication of cell kinetic changes during the progression of human prostatic cancer.
RR Berges, J Vukanovic, JI Epstein, M CarMichel, L Cisek, DE Johnson, ...
Clinical cancer research: an official journal of the American Association …, 1995
4961995
Down-Regulation of the KAI1 Metastasis Suppressor Gene during the Progression of Human Prostatic Cancer Infrequently Involves Gene Mutation or Allelic Loss
JT Dong, H Suzuki, SS Pin, GS Bova, JA Schalken, WB Isaacs, JC Barrett, ...
Cancer Research 56 (19), 4387-4390, 1996
4061996
The biology of hormone refractory prostate cancer: Why does it develop?
JT Isaacs
Urologic Clinics of North America 26 (2), 263-273, 1999
3971999
The role of calcium, pH, and cell proliferation in the programmed (apoptotic) death of androgen-independent prostatic cancer cells induced by thapsigargin
Y Furuya, P Lundmo, AD Short, DL Gill, JT Isaacs
Cancer research 54 (23), 6167-6175, 1994
3961994
Clinical evidence for and implications of the multistep development of prostate cancer
HB Carter, S Piantadosi, JT Isaacs
The Journal of urology 143 (4), 742-746, 1990
3551990
Prostate-specific antigen-activated thapsigargin prodrug as targeted therapy for prostate cancer
SR Denmeade, CM Jakobsen, S Janssen, SR Khan, ES Garrett, H Lilja, ...
Journal of the National Cancer Institute 95 (13), 990-1000, 2003
3532003
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20